Neuronal FasL induces cell death of encephalitogenic T lymphocytes

Brain Pathology

Volumn 10, Issue 3, 2000, Pages 353-364

  Flugel A ^a   Schwaiger, F W ^a   Neumann, H ^a   Medana, I ^a   Willem, M ^b   Wekerle, H ^a   Kreutzberg, G W ^a   Graeber, Manuel B ^a,c  

^a MAX PLANCK INSTITUTE OF NEUROBIOLOGY   (Germany)

^b MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^c IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; FAS ANTIGEN; GREEN FLUORESCENT PROTEIN; LIGAND;

ADOLESCENT; ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; FACIAL NERVE; GENE EXPRESSION; HELPER CELL; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; NERVE FIBER TRANSECTION; NONHUMAN; RAT; T LYMPHOCYTE;

EID: 0343496952     PISSN: 10156305     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1750-3639.2000.tb00267.x     Document Type: Article

References (58)

1. Abbas AK (1996) Die and let live: eliminating dangerous lymphocytes. Cell 84:655-657.
2. Bachmann R, Eugster H-P, Frei K, Fontana A, Lassmann H (1999) Impairment of TNF-receptor-1 signaling but not Fas signaling diminishes T-cell apoptosis in myelin oligodendrocyte glycoprotein peptide-induced chronic demyelinating autoimmune encephalomyelitis in mice. Am J Pathol 154: 1417-1422.
3. Bauer J, Bradl M, Mickey WF, Forss-Petter S, Breitschopf H, Linington C, Wekerle H, Lassmann H (1998) T-cell apoptosis in inflammatory brain lesions: destruction of T cells does not depend on antigen recognition. Am J Pathol 153:715-724.
4. Bechmann I, Mor G, Nilsen J, Eliza M, Nitsch R, Naftolin F (1999) FasL (CD95L, Apo1L) is expressed in the normal rat and human brain: evidence for the existence of an immunological brain barrier. Glia 27: 62-74.
5. Bellgrau D, Gold D, Selawry H, Moore J, Franzusoff A, Duke RC (1995) A role for CD95 ligand in preventing graft rejection. Nature 19;377:630-632.
6. Ben-Nun A, Wekerle H, Cohen IR (1981) The rapid isolation of clonable antigen-specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis. Eur J Immunol 11:195-199.
7. Betz WJ, Bewick GS (1992) Optical analysis of synaptic vesicle recycling at the frog neuromuscular junction. Science 255: 200-203.
8. Bonetti B, Pohl J, Gao YL, Raine CS (1997) Cell death during autoimmune demyelination: effector but not target cells are eliminated by apoptosis. J Immunol 159:5733-5741.
9. Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
10. Dittel BN, Merchant RM, Janeway CA (1999) Evidence for Fas-dependent and Fas-independent mechanisms in the pathogenesis of experimental autoimmune encephalomyelitis. J Immunol 162: 6392-6400.
11. Dowling P, Shang G, Raval S, Menonna J, Cookand S, Husar W (1996) Involvment of the CD95 (APO-1/Fas) receptor/ligand system in multiple sclerosis brain. J Exp Med 184: 1513-1518.
12. D'Souza SD, Bonetti B, Balasingam V, Cashman NR, Barker PA, Troutt AB, Raine CS, Antel JP (1996) Multiple sclerosis: Fas signaling in oligodendrocyte death. J Exp Med 184: 2361-2370.
13. Ehrhard PB, Erb P, Graumann U, Otten U (1993) Expression of nerve growth factor and nerve growth factor receptor tyrosine kinase Trk in activated CD4-positive T-cell clones. Proc Natl Acad Sci USA 90:10984-10988.
14. Eylar EH, Kniskern PJ, Jackson JJ (1974) Myelin basic proteins. Methods Enzymol 32:323-341.
15. Fisher GH, Rosenberg FJ, Straus SE, Dale JK, Middleton LA, Lin AY, Strober W, Lenardo MJ, Puck JM (1995) Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81:935-946.
16. Flügel A, Willem M, Berkowicz T, Wekerle H (1999b) Gene transfer into CD4+ T lymphocytes: Green fluorescent protein-engineered, encephalitogenic T cells illuminate brain autoimmune responses. Nature Med 5:843-847.
17. Flügel A, Labeur, M, Grasbon-Frodl EM, Kreutzberg GW, Graeber MB (1999) Microglia only weakly present glioma antigen to cytotoxic T cells. Intl J Devel Neurosci: 17: 547-556.
18. Fontana A, Fierz W, Wekerle H (1984) Astrocytes present myelin basic protein to encephalitogenic T-cell lines. Nature 307:273-276.
19. Frei K, Siepl C, Groscurth P, Bodmer S, Schwerdel C, Fontana A (1987) Antigen presentation and tumor cytotoxicity by interferon-gamma-treated microglial cells. Eur J Immunol 17:1271-1278.
20. Freidin M, Bennett MV, Kessler JA (1992) Cultured sympathetic neurons synthesize and release the cytokine interleukin 1 beta. Proc Natl Acad Sci USA 89:10440-10443.
21. French LE, Hahne M, Viard I, Radlgruber G, Zanone R, Becker K, Muller C, Tschopp J (1996) Fas and Fas ligand in embryos and adult mice: ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover. J Cell Biol 133:335-343.
22. Gavrieli Y, Sherman Y, Ben-Sasson SA (1992) Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119:493-501.
23. Graeber MB, Streit WJ, Kreutzberg GW (1989) Formation of microglia-derived brain macrophages is blocked by adriamycin. Acta Neuropathol 78:348-358.
24. Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA (1995) Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 270:1189-1192.
25. Hager G, Eckert E, Schwaiger FW (1999) Semiquantitative analysis of low levels of mRNA expression from small amounts of brain tissue by non-radioactive reverse transcriptase-polymerase chain reaction. J Neurosci Meth 89:141-149.
26. Hughes D, Raine CS, Field EJ (1968) Invasion of neurons in vitro by non immune lymphocytes. An electron microscopic study. Brit J Exp Path 49: 356-359.
27. Hünig T, Schimpl A (1997) Systemic autoimmune disease as a consequence of defective lymphocyte death. Curr Opin Immunol 9:826-830.
28. Kerschensteiner M, Gallmeier E, Behrens L, Leal VV, Misgeld T, Klinkert WEF, Kolbeck R, Hoppe E, Oropeza-Wekerle RL, Bartke I, Stadelmann C, Lassmann H, et al. (1999) Activated human T cells, B cells, and monocytes produce brain- derived neurotrophic factor in vitro and in inflammatory brain lesions: A neuroprotective role of inflammation? J Exp Mod 189:865-870.
29. Kohji T, Tanuma N, Aikawa Y, Kawazoe Y, Suzuki Y, Kohyama K, Matsumoto Y (1998) Interaction between apoptotic cells and reactive brain-cells in the central-nervous-system of rats with autoimmune encephalomyelitis. J Neuroimmunol 82:168-174.
30. Konno H, Yamamoto T, Suzuki H, Yamamoto H, Iwasaki Y, Ohara Y, Terunuma H, Harata N (1990) Targeting of adoptively transferred experimental allergic encephalitis lesion at the sites of Wallerian degeneration. Acta Neuropathol 80:521-526.
31. Laouar Y, Sarukhan A, Pasqualetto V, Garcia C, Ezine S (1998) Involvement of the Fas (CD95) system in peripheral cell death and lymphoid organ development. Eur J Immunol 28:1078-1088.
32. Maehlen J, Olsson T, Zachau A, Klareskog L, Kristensson K (1989) Local enhancement of major histocompatibility complex (MHC) class I and II expression and cell infiltration in experimental allergic encephalomyelitis around axotomized motor neurons. J Neuroimmunol 23:125-132.
33. Markowitz D, Goff S, Bank A (1988) A safe packaging line for gene transfer: separating viral genes on two different plasmids. J Virol 62:1120-1124.
34. Miller AD, Rosman GJ (1989) Improved retroviral vectors for gene transfer and expression. Biotechniques 7:980-982.
35. Moalem G, Leibowitz-Amit R, Yoles E, Mor F, Cohen IR, Schwartz M (1999a) Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy. Nature Wed 5:49-55.
36. Moalem G, Monsonego A, Shani Y, Cohen IR, Schwartz M (1999b) Differential T cell response in central and peripheral injury: connection with immune privilege. FASEB J 13: 1207-1217.
37. Nagata S, Golstein P (1995a) The Fas death factor. Science 267:1449-1456.
38. Nagata S, Suda T (1995b) Fas and Fas ligand: Ipr and gld mutations. Immunol Today 16:39-43.
39. Neumann H, Cavalie A, Jenne DE, Wekerle H (1995) Induction of MHC class I genes in neurons. Science 269:549-552.
40. Nguyen KB, Mccombe PA, Pender MP (1997) Increased apoptosis of T-lymphocytes and macrophages in the central and peripheral nervous systems of lewis rats with experimental autoimmune encephalomyelitis treated with dexamethasone. J Neuropathol Exp Neurol 56:58-69.
41. Pender MP, Nguyen KB, Mccombe PA, Kerr JFR (1991) Apoptosis in the Nervous System in Experimental Allergic Encephalomyelitis. J Neurol Sci 104:81-87.
42. Pette M, Fujita K, Kitze B, Whitaker JN, Albert E, Kappos L, Wekerle H (1990) Myelin basic protein-specific T lymphocyte lines from MS patients and healthy individuals. Neurology 40:1770-1776.
43. Phelouzat MA, Laforge T, Arbogast A, Quadri RA, Boutet S, Proust JJ (1997) Susceptibility to apoptosis of T lymphocytes from elderly humans is associated with increased in vivo expression of functional Fas receptors. Mechanisms of Ageing & Development 96:35-46.
44. Risau W, Engelhardt B, Wekerle H (1990) Immune function of the blood-brain barrier - incomplete presentation of protein (auto)antigens by rat brain microvascular endothelium in vitro. J Cell Biol 110:1757-1766.
45. Saas P, Walker PR, Hahne M, Quiquerez AL, Schnuriger V, Perrin G, French L, Van Meir EG, de Tribolet N, Tschopp J, Dietrich PY (1997) Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain? J Clin Invest 99:1173-1178.
46. Sabelko KA, Kelly KA, Nahm MH, Cross AH, Russell JH (1997) Fas and Fas ligand enhance the pathogenesis of experimental allergic encephalomyelitis, but are not essential for immune privilege in the central nervous system. J Immunol 159:3096-3099.
47. Sabelko-Downes KA, Cross AH, Russell JH (1999) Dual role for Fas ligand in the initiation and recovery from experimental allergic encephalomyelitis. J Exp Med 189: 1195-1206.
48. Schmied M, Breitschopf H, Gold R, Zischler H, Rothe G, Wekerle H, Lassmann H (1993) Apoptosis of T lymphocytes in experimental autoimmune encephalomyelitis -evidence for programmed cell death as a mechanism to control inflammation in the brain. Am J Pathol 143:446-452.
49. Schmitt AB, Breuer S, Voell M, Schwaiger FW, Spitzer C, Pech K, Brook GA, Noth, J, Kreutzberg GW, Nacimiento W (1999) GAP-43 (B-50) and C-Jun are up-regulated in axotomized neurons of Clarke's nucleus after spinal cord injury in the adult rat. Neurobiol Disease 6:122-130.
50. Streilein JW (1995) Unraveling immune privilege. Science 270:1158-1159.
51. Suda T, Takahashi T, Golstein R Nagata S (1993) Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75:1169-1178.
52. Sun D, Whitaker JN, Cao L, Han Q, Sun S, Coleclough C, Mountz J, Zhou T (1998) Cell death mediated by Fas-FasL interaction between glial cells and MBP-reactive T cells. J Neurosci Res 52: 458-467.
53. Tchelingerian JL, Le Saux F, Jacque C (1996) Identification and topography of neuronal cell populations expressing TNF alpha and IL-1 alpha in response to hippocampal lesion. J Neurosci Res 43:99-106.
54. Van Parijs L, Abbas AK (1996a) Role of Fas-mediated cell death in the regulation of immune responses. Curr Opin Immunol 8:355-361.
55. Van Parijs L, Ibraghimov A, Abbas AK (1996b) The roles of costimulation and Fas in T cell apoptosis and peripheral tolerance. Immunity 4:321-328.
56. Waldner H, Sobel RA, Howard E, Kuchroo VK (1997) Fas-and FasL-deficient mice are resistant to induction of autoimmune encephalomyelitis. J Immunol 159:3100-3103.
57. Wekerle H, Linington C, Lassmann H, Meyermann R (1986) Cellular immune reactivity within the CNS. Trends Neurosci 9: 271-277
58. Xiao BG, Link H (1998) Immune regulation within the central nervous system. J Neurol Sci 157:1-12.